Table 2 Patients’ baseline variables and presenting complaints
Overall | Died | Survived | Relative risk | P-value | |
|---|---|---|---|---|---|
N = 752 | N = 16 | N = 736 | |||
Clinical characteristics | n (%) | n (%) | n (%) | RR (95%CI) | |
Tachypnea b | 336 (44.7) | 10 (62.5) | 326 (44.3) | 2.1 (0.8–5.7) | 0.16 |
Tachycardiab | 186 (24.7) | 5 (31.3) | 181 (24.6) | 1.4 (0.5–3.9) | 0.5 |
Febrile (T > 37.5 °C)c | 131 (17.4) | 11 (68.8) | 120 (16.3) | 10.4 (3.7–29.5) | < 0.0001 |
SpO2a < 95% | 67 (8.9) | 15 (93.8) | 52 (7.1) | 153 (20–1143) | < 0.0001 |
Altered mental status | 59 (7.8) | 13 (81.3) | 46 (6.3) | 50 (15–174) | < 0.0001 |
Bradycardiab | 14 (1.9) | 3 (18.8) | 11 (1.5) | 12.1 (3.9–38.0) | < 0.0001 |
Pain | 614 (81.6) | 12 (75.0) | 602 (81.8) | 0.7 (0.2–2.1) | 0.5 |
Fever | 289 (38.4) | 10 (62.5) | 279 (37.9) | 2.7 (1.0–7.3) | 0.06 |
Abdominal Symptoms | 159 (21.1) | 2 (12.5) | 157 (21.3) | 0.5 (0.1–2.3) | 0.4 |
Respiratory Symptoms | 156 (20.7) | 11 (68.8) | 145 (19.7) | 8.4 (3.0–23.8) | 0.0001 |
Cardiovascular Symptoms | 83 (11.0) | 2 (12.5) | 81 (11.0) | 1.2 (0.3–5.0) | 0.9 |
Jaundice | 80 (10.6) | 1 (6.3) | 79 (10.7) | 0.6 (0.1–4.2) | 0.6 |
Body Swelling | 54 (7.2) | 2 (12.5) | 52 (7.1) | 1.9 (0.4–7.9) | 0.4 |
Neurological Symptoms | 45 (6.0) | 6 (37.5) | 39 (5.3) | 9.4 (3.6–24.8) | < 0.0001 |
Long Lasting Erection | 20 (2.7) | 1 (6.3) | 19 (2.6) | 2.4 (0.3–17.6) | 0.4 |
Urinary Symptoms | 6 (0.8) | 1 (6.3) | 5 (0.7) | 8.3 (1.3–53.1) | 0.03 |